A COLLABORATIVE EFFORT BETWEEN TRANSLATIONAL GENOMICS RESEARCH INSTITUTE AND THE IVY EARLY PHASE CLINICAL TRIALS CONSORTIUM (UCSF, UCLA, MSKCC, MGH, DFCC, MD Anderson, Un. of Utah) TO DEVELOP INNOVATIVE CLINICAL TRIALS FOR GBM PATIENTS WHICH WILL MATCH AN INDIVIDUAL’S MOLECULAR PATHOLOGY TO TARGETED THERAPIES, INCLUDING ALIGNING GENOMIC INFORMATION, GLIOMA BIOLOGY, PRECISION GUIDED DELIVERY AND ACCESS TO NEW AGENTS.